Introduction: Kidney transplantation is the preferred treatment for end-stage renal disease, but immune-mediated graft dysfunction remains a major barrier to long-term success. Conventional indicators such as serum creatinine and proteinuria are not immune-specific, and kidney biopsy is unsuitable for routine use. Mitochondrial function, a critical regulator of immune activation, may provide novel biomarkers for immune monitoring in transplantation. Methods: In this study, the percentage of peripheral immune cells with low mitochondrial membrane potential (MMP-Low%) and mitochondrial mass (MM) were assessed in 30 kidney transplant recipients and 44 healthy controls. Of the 30 transplant recipients, 15 provided paired samples before transplantation and at one month after transplantation with preserved graft function, while the other 15 had impaired graft function. Flow cytometry was used to measure lymphocyte subsets and mitochondrial parameters, which were further evaluated across specific T cell populations. Results: The results showed that increased age correlated with lower MMP-Low% and higher MM. Patients with impaired graft function showed significantly reduced MMP-Low% and elevated MM, suggesting enhanced metabolic activation, while those with preserved graft function displayed increased MMP-Low% and decreased MM, reflecting a quiescent metabolic profile consistent with immunosuppression. Discussion: These findings indicate that peripheral T cell mitochondrial metrics may serve as sensitive, dynamic, and non-invasive biomarkers for post-transplant immune monitoring.
Anti‐ N‐methyl‐D‐aspartate receptor encephalitis (NMDAR‐E) is a prevalent autoimmune neurological disorder, yet T cell‐driven immunopathology and its contributions to therapeutic resistance and fulminant neuroinflammation remain poorly defined. Integrative single‐cell multi‐omic profiling, combining single‐cell RNA sequencing, single‐cell T cell receptor (TCR) sequencing, and cellular indexing of transcriptomes and epitopes by sequencing, is applied to systematically map peripheral and cerebrospinal fluid (CSF) immune landscapes in treatment‐naïve NMDAR‐E patients, with orthogonal validation conducted across independent cohorts via multiparameter flow cytometry and ex vivo NR1 peptide stimulation. Clonally expanded CX3CR1‐expressing CD4 + and CD8 + T cells are identified as a core disease‐associated effector population, characterized by high predicted affinity for the pathogenic GluN1 N368/G369 epitope, robust proinflammatory and cytotoxic transcriptional programs, and enhanced intercellular crosstalk with activated B cells through major histocompatibility complex (MHC), CD99, and macrophage migration inhibitory factor signaling axes. Preferentially enriched in patient CSF, these cells produce elevated interferon‐γ (IFN‐γ) and tumor necrosis factor‐α (TNF‐α) upon antigen‐specific stimulation, collectively highlighting a disease‐associated inflammatory T cell state linked to peripheral immune activation and CNS immune remodeling, with potential translational relevance for future biomarker and therapeutic investigation.
There is currently no standardized model for assessing immune aging, which may contribute to the development and clinical progression of age-related diseases. We have developed an immune-age prediction model and conducted preliminary validation in patients. A total of 523 healthy adults were recruited for the establishment of the model. Additionally, 53 patients with hematological tumors, 38 patients who had experienced a stroke, and 105 patients with COVID-19 infection were enrolled as the validation cohort. Flow cytometric analysis was conducted to obtain results for 50 TBNK lymphocyte subsets. The proportion of patients exhibiting an immune age older than their actual age was 81.13% (43/53), 57.89% (22/38), and 65.71% (69/105) in individuals diagnosed with hematological tumors, stroke, and COVID-19 infection, respectively. In stroke patients with poor prognosis, the modified Rankin Scale (mRS) score at 90 days demonstrated a significant positive correlation with immune age (P < 0.01). The practical and convenient model demonstrated superior performance in assessing immunosenescence compared to chronological age. Our findings provide preliminary evidence linking early immune aging to adverse outcomes in stroke patients, suggesting its potential as a predictor that warrants further investigation in larger cohorts.
Kidney transplantation is currently the most effective method for treating end-stage renal disease. However, postoperative-related rejection and IgA nephropathy remains a serious obstacle to the long-term survival of kidney transplant patients. Its pathogenesis is not fully understood, and potential causative factors remain to be explored. In this study, we used 2bRAD-M to analyze differences in the peripheral blood microbiome of renal transplant recipients who were stable postoperatively (STABLE) and those who developed chronic antibody-mediated rejection (CAMR) or IgA nephropathy (IgAN) recurrence. Thirty one renal transplant patients were recruited, including 12 STABLE, 8 CAMR and 11 IgAN patients after kidney transplantation. 2bRAD-M was used to characterize the microbiota in peripheral blood to explore the presence of microbial differences. Differences in microbial community composition were observed between CAMR, IgAN and STABLE. The alpha diversity of CAMR and IgAN was all higher than STABLE, there are also differences in beta diversity. LEfSe was performed to identify different abundance taxa, 21 discriminative features between CAMR and STABLE, 39 discriminative features between IgAN and STABLE. The mean decrease Gini index and random forest analysis indicated that Staphylococcus_epidermidis might serve as indicator bacteria for CAMR, Kocuria_palustris might serve as indicator bacteria for IgAN. ROC analysis was performed to assess the performance of some optimal marker models, and the average AUC value achieved 89.6% between CAMR and STABLE, 67.4% between IgAN and STABLE. Functional annotation analysis showed 4353 different COGs and 378 related signaling pathways between CAMR and STABLE, 4396 different COGs and 384 related signaling pathways between CAMR and STABLE. The first 2bRAD-M microbiome study of CAMR and IgAN after renal transplantation showed a potential association between the circulating microbiome and the disease, and provided a possible target and basis for subsequent studies of the mechanisms underlying the development and progression of CAMR and IgAN after renal transplantation.